Company Filing History:
Years Active: 2014
Title: Shuangming Wang: Innovator in Diabetes Treatment
Introduction
Shuangming Wang is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes. His innovative approach has led to the development of a unique pharmaceutical composition aimed at managing diabetes mellitus.
Latest Patents
Wang holds a patent for a pharmaceutical composition for treating diabetes and its process for preparation. This invention relates to methods for preparing a pharmaceutical composition that includes extracts from various crude drugs. The composition comprises 5-40 weight parts of Tianhuafen, 10-30 weight parts of Chaihu, 3-15 weight parts of Zhishi, 1-6 weight parts of Dahuang, 1-12 weight parts of Banxia, 3-15 weight parts of Huangqin, 1-12 weight parts of Huanglian, 3-15 weight parts of Baishao, and 5-20 weight parts of Wumei. Additionally, it may optionally include pharmaceutically acceptable excipients and can further comprise Shanzha. The invention also discloses four methods for preparing the pharmaceutical composition.
Career Highlights
Shuangming Wang is associated with Tasly Pharmaceutical Group Co., Ltd., a prominent company in the pharmaceutical industry. His work focuses on innovative solutions for health challenges, particularly in diabetes management.
Collaborations
Wang has collaborated with notable colleagues, including Xiaolin Tong and Yonghong Zhu, to advance research and development in his field.
Conclusion
Shuangming Wang's contributions to diabetes treatment through his innovative pharmaceutical composition highlight his role as a key inventor in the healthcare sector. His work continues to impact the lives of those affected by diabetes.